Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04545229 · ClinicalTrials.gov registry record · NA

VR for Pain Management During Adult Burn Dressing Change

A NA study of Pain and Burns, sponsored by Nationwide Children's Hospital.

Completed
Registry status
NA
Development phase
14
Enrollment target
1
Study location

NCT04545229: Completed NA study of Pain and Burns, sponsored by Nationwide Children's Hospital.

NCT04545229 is a NA study of Pain and Burns that has completed, run by Nationwide Children's Hospital. The registered enrollment target is 14 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04545229, a NA study of Pain and Burns, has completed, sponsored by Nationwide Children's Hospital.

COMPLETED
Registry status
NA
Development phase
14 participants
Enrollment target
1
Study location

Study Summary

A randomized controlled trial to evaluate the efficacy of the VR-based Pain Alleviation Tool (VR-PAT) in reducing opioid pain medication use during adult burn dressing changes.

Primary Outcome

Patient self-reported pain using the 100mm Visual Analog Scale (VAS), 0 (min)-100(max), higher score for worse outcome.

Conditions Studied

Interventions

  • OTHER VR-based Pain Alleviation Tool (VR-PAT)

Study Locations (1)

Ohio

  • Nationwide Children's Hospital - Columbus

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2019-02-01
Est. Completion 2019-11-24
Phase NA
Nationwide Children's Hospital

188 total trials

What the finished NCT04545229 record still lists

NCT04545229 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 304-participant average among 374 other Pain trials with a reported enrollment target (95% lower).

The record links to 2 conditions, with Pain appearing as the primary indexed condition, and to 1 intervention - of which VR-based Pain Alleviation Tool (VR-PAT) is the first listed.

NCT04545229 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT04545229 about?

NCT04545229 is a clinical study titled "VR for Pain Management During Adult Burn Dressing Change". A randomized controlled trial to evaluate the efficacy of the VR-based Pain Alleviation Tool (VR-PAT) in reducing opioid pain medication use during adult burn dressing changes.

What is the current status of trial NCT04545229?

This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2019-02-01. Estimated completion is 2019-11-24.

What conditions does trial NCT04545229 study?

This clinical trial studies the following conditions: Pain, Burns.

What interventions are being tested in trial NCT04545229?

The interventions under investigation include: VR-based Pain Alleviation Tool (VR-PAT) (OTHER).

Who is sponsoring clinical trial NCT04545229?

This trial is sponsored by Nationwide Children's Hospital, which has 188 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04545229 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04545229's enrollment target sits among peer trials

14 355th of 374 higher than 19 of 374 other Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02523092 · 14 participants · Phase 4

    Use of CXCL9 as a Biomarker of Acthar Efficacy

  • NCT04263285 · 14 participants · NA

    Treatment of Depression Post-SCI

  • NCT04743271 · 14 participants · NA

    Food and Circadian Timing

  • NCT05065671 · 14 participants · Phase 1

    Microbiome Derived Metabolism and Pharmacokinetics

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT06358040 · started 2026-10 · NA

    Opioid Dispenser for Microdiscectomy/Laminectomy

Source: ClinicalTrials.gov NCT04545229, the US trial registry maintained by the National Library of Medicine. NCT04545229 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.